Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomized controlled trial
Both your prescribing physician for tirzepatide and your mental health provider should be aware of all your medications
Fatigue during early GLP-1 treatment typically reflects either rapid calorie restriction (if you're eating too little), medication side effects like nausea reducing nutrient intake, or dehydration
[19] [20] If you are unsure whether your symptoms require urgent attention, NHS 111 can provide advice
The outcomes captured were incident cases of ESKD, hospitalisation for MI, stroke and HF, years of life lived, quality-adjusted life years (QALYs), healthcare costs and societal costs
It sounds like theyre really going to be impacted by these formulary exclusions